Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT06259019
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- PlaqueTec Ltd
- Registry
-
NCT06259019
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06259019. Allocation not applicable; no masking; primary purpose other. Start 2023-09-14 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
- Acronym
- BIOPATTERN
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Liquid Biopsy System (LBS)
- Lead sponsor
- PlaqueTec Ltd
- Collaborator
- Royal Papworth Hospital
Record details
- Record id
cardio:ct-nct06259019- Content hash
cb84e35c81d8c2905f922c92d0649017998f374a442de8280c40e50e9b136089